Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review

Epidemiologia e Psichiatria Sociale

Volumn 19, Issue 3, 2010, Pages 233-242

  Burton, Alexandra ^a   Marougka, Stamatina ^a   Priebe, Stefan ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Health behaviour; Incentives; Patient non adherence; Review; Systematic

Indexed keywords

HOSPITALIZATION; HUMAN; MENTAL DISEASE; MOTIVATION; PATIENT COMPLIANCE; REVIEW;

HUMANS; MENTAL DISORDERS; MOTIVATION; PATIENT COMPLIANCE; SEVERITY OF ILLNESS INDEX;

EID: 78649287640     PISSN: 1121189X     EISSN: 20381816     Source Type: Journal    
DOI: 10.1705/524.6267     Document Type: Review

References (31)

1. Appleby L. (2000). Safer services: conclusions from the report of the National Confidential Inquiry. Advances in Psychiatric Treatment 6, 5-15.
2. Burns T. (2007). Is it acceptable for people to be paid to adhere to medication? Yes. British Medical Journal 335, 232-233.
3. Burns T., Catty J., Dash M., Roberts C., Lockwood A. & Marshall M. (2007). Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and metaregression. British Medical Journal 335, 336-336.
4. Carey K.B. & Carey M.P. (1990). Enhancing the treatment attendance of mentally ill chemical abusers. Journal of Behavior Therapy and Experimental Psychiatry 21, 205-209.
5. Claassen D., Fakhoury W.K., Ford R. & Priebe S. (2007). Money for medication: Financial incentives to improve medication adherence in assertive outreach. Psychiatric Bulletin 31, 4-7.
6. Drebbing C.E., Van Ormer A., Krebs C., Rosenheck R., Rounsaville B., Herz L. & Penk W. (2005). The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. Journal of Applied Behavior Analysis 38, 359-372.
7. Fenton S.W., Blyler C.R. & Heinssen R.K. (1997). Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23, 637-651.
8. Gilmer T.P., Dolder C.R., Lacro J.P., Folsom D.P., Lindamer L., Garcia P. & Jeste D.V. (2004). Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161, 692-699.
9. Giuffrida A. & Togerson D.J. (1997). Should we pay the patient? Review of financial incentives to enhance patient compliance. British Medical Journal 315, 703-707.
10. Helmus T.C., Schoener E.P. & Roll J.M. (2003). Reinforcement of counselling attendance and alcohol abstinence in a community based dual-diagnosis treatment program: a feasibility study. Psychology of Addictive Behaviors 17, 249-251.
11. Jochelson K. (2007). Paying the Patient. Improving Health Using Financial Incentives. Kings Fund.
12. Killaspy H., Bebbington P., Blizard R., Johnson S., Nolan F., Pilling S. & King M. (2006). The REACT study: randomised evaluation of assertive community treatment in north London. British Medical Journal 332, 815-20.
13. Lacro J.P., Dunn L.B. & Dolder C.R. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63, 892-909.
14. Mcdonald H.P., Garg A.X. & Haynes R.B. (2002). Interventions to enhance patient adherence to medication prescriptions. Scientific review. Journal of the American Medical Association 288, 2868-2879.
15. Messina N., Farabee D. & Reason R. (2003). Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioural and contingency management interventions. Journal of Consulting and Clinical Psychology 71, 320-329.
16. Monahan J., Redlich A.D., Swanson J., Clark Robbins P., Appelbaum P.S., Petrila J., Steadman H.J., Swartz M., Angell B. & McNiel D.E. (2005). Use of leverage to improve adherence to psychiatric treatment in the community. Psychiatric Services 56, 37-44.
17. National Institute for Clinical Excellence. (2009). Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). NICE: London.
18. Nosè M. (2008). Tolerability of antipsychotic drugs: does patient perspective deserve consideration? Epidemiologia e Psichiatria Sociale 17, 182-185.
19. Nosé M., Barbui C., Gray R. & Tansella M. (2003). Clinical interventions for treatment non-adherence in psychosis: meta-analysis. British Journal of Psychiatry 183, 197-206.
20. O'Donnell C., Donohoe G., Sharkey L., Owens N., Migone M., Harries R., Kinsella A., Larkin C. & O'Callaghan E. (2003). Compliance therapy: A randomised controlled trial in schizophrenia. British Medical Journal 327(7419), 834.
21. Olson P.R. & Greenberg D.J. (1979). Effects of contingency- contracting and decision-making groups with chronic mental patients. Journal of Consulting and Clinical Psychology 38, 376-383.
22. Post E.P., Cruz M. & Harman J. (2006). Incentive payments for attendance at appointments for depression among low-income African Americans. Psychiatric Services 57, 414-416.
23. Priebe S., Burton A., Ashby D., Ashcroft R., Burns T., David A., Eldridge S., Firn M., Knapp M. & McCabe R (2009). Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT), BMC Psychiatry [online]. Retrieved April 12, 2009, from http://www.biomedcentral.com/1471- 244X/9/61
24. Roll J.M., Higgins S.T., Steingard S. & Mcginley M. (1998) Use of monetary reinforcement to reduce cigarette smoking of persons with schizophrenia: a feasibility study. Experimental and Clinical Psychopharmacology 6, 157-161.
25. Roll J.M., Chermack S.T. & Chudzynski J.E. (2004). Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Research 125, 61-64.
26. Shaner A., Roberts L.J., Eckman T.A., Tucker D.E., Tsuang J.W., Wilkins J.N. & Mintz J. (1997). Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatric Services 48, 807-810.
27. Shaw J. (2007). Is it acceptable for people to be paid to adhere to medication? No. British Medical Journal 335, 232-233.
28. Sigmon S.C., Steingard S., Badger G.J., Anthony S.L. & Higgins S.T. (2000). Contingent reinforcement of marijuana abstinence among individuals with severe mental illness: a feasibility study. Experimental and Clinical Psychopharmacology 8, 509-517.
29. Thyer B.A., Irvine S. & Santa C.A. (1984). Contingency management of exercise by chronic schizophrenics. Perceptual Motor Skills 58, 419-425.
30. Tidey J.W., O'Neill S.C. & Higgins S.T. (2002). Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental and Clinical Psychopharmacology 10, 241-247
31. Tracy K., Babuscio T., Mich C., Kiluk B., Carroll K.M., Petry N.M. & Rounsaville B.J. (2007). Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse 33, 253-258.